UPDATE: The video and slides [PDF] from the MIRA webinar are now available.
We recently reissued the funding opportunity announcement (FOA) for the Maximizing Investigators’ Research Award (MIRA) for Early Stage Investigators (PAR-20-117). The first application due date is October 2, 2020.
We’re hosting a webinar to discuss this FOA and to answer your questions about the program on Thursday, August 6, 1:00-2:30 p.m. ET. To access the webinar, visit the WebEx meeting page (link no longer available). We plan to post the archived webinar and slides on the MIRA webpage after the event.
Continue reading “Webinar and Other Resources for New MIRA ESI Funding Opportunity”
One of the most common questions we receive about the Maximizing Investigators’ Research Award (MIRA) program is the likelihood of an application’s funding given a certain overall impact score.
Frequent readers of this blog may note that we typically provide statistics as they relate to our R01 portfolio, but we’ve yet to provide a similar “funding curve” for the MIRA program. One reason that MIRA applications haven’t been included in these analyses is that, unlike most R01 applications, MIRA R35 applications don’t receive a percentile score. The percentile score allows for normalization of overall impact scores across study sections to account for any differences in scoring behavior that are observed in review panels. See the Office of Extramural Research’s comprehensive blog post for more information about overall impact scores and percentiles.
Continue reading “Funding Trends: MIRA Applications and Overall Impact Scores”
Ninety percent of the applications to our Maximizing Investigators’ Research Award for Early Stage Investigators (known as the ESI MIRA program) that were submitted in October are about to undergo peer review. The remaining 10% were administratively withdrawn, mostly because the research proposed fell outside the NIGMS mission. This is comparable to the proportion that was withdrawn over the past 3 years.
Withdrawn applications represent a lot of wasted time and effort on the part of affected PIs and are the source of considerable frustration. So what can you do to minimize the chance of this happening to your ESI MIRA application in the future?
Continue reading “How do I know if my work fits in the mission of NIGMS?”
We’ve issued a funding opportunity announcement (FOA) PAR-19-367
to maintain continued support of our Maximizing
Investigators’ Research Award (MIRA) program. Under this new FOA,
investigators with an active NIGMS R35 grant (both early-stage and established
investigator MIRA) can submit renewal MIRA applications, and investigators with
a single-PI R01-equivalent NIGMS award (DP1, DP2, R01, R37, SC1) can submit new
Continue reading “NIGMS Continues Its MIRA Program”
NIGMS has made MIRA awards to Established Investigators (EI) and Early-Stage Investigators (ESI) for three full Fiscal Years (FY). In this Feedback Loop post, we provide an analysis of application, review, funding, and demographic trends for the MIRA program.
For the first two rounds of EI MIRAs, eligibility was limited to well-funded NIGMS investigators: PIs with two or more NIGMS R01-equivalent awards or one NIGMS R01-equivalent award for >$400,000 in direct costs. For the FY 2018 EI competition and beyond, eligibility was expanded to include any investigator with a single PD/PI NIGMS R01-equivalent that is up for renewal. For the FY 2016 ESI MIRA competition, ESIs and New Investigators (NI) at the assistant professor or equivalent level were eligible, whereas eligibility was restricted to ESIs in subsequent rounds. As always, a PI can apply for an extension of ESI status for various life and career events, including childbirth.
Continue reading “Application, Review, Funding, and Demographic Trends for Maximizing Investigators’ Research Awards (MIRA): FY 2016-2018”
UPDATE: The chart below was updated in June 2020. Revisions to the R35 program are allowable to address special research priorities, e.g. COVID-19.
Since supplemental grant funding comes in a variety of flavors, with different purposes, it’s not surprising that there’s confusion about which kinds of supplements MIRA grantees may apply for and which they may not. Here’s a quick run-down.
Continue reading “Supplements for MIRAs: Clarifying the Policy”